Literature DB >> 10332004

Feeding problems in merosin deficient congenital muscular dystrophy.

J Philpot1, A Bagnall, C King, V Dubowitz, F Muntoni.   

Abstract

Feeding difficulties were assessed in 14 children (age range 2-14 years) with merosin deficient congenital muscular dystrophy, a disease characterised by severe muscle weakness and inability to achieve independent ambulation. Twelve of the 14 children were below the 3rd centile for weight. On questioning, all parents thought their child had difficulty chewing, 12 families modified the diet, and 13 children took at least 30 minutes to complete a meal. On examination the mouth architecture was abnormal in 13 children. On videofluoroscopy only the youngest child (2 years old), had a normal study. The others all had an abnormal oral phase (breakdown and manipulation of food and transfer to oropharynx). Nine had an abnormal pharyngeal phase, with a delayed swallow reflex. Three of these also showed pooling of food in the larynx and three showed frank aspiration. These six cases all had a history of recurrent chest infections. Six of eight children who had pH monitoring also had gastro-oesophageal reflux. As a result of the study five children had a gastrostomy, which stopped the chest infections and improved weight gain. This study shows that children with merosin deficient congenital muscular dystrophy have difficulties at all stages of feeding that progress with age. Appropriate intervention can improve weight gain and reduce chest infections. The severity of the problem has not been previously appreciated in this disease, and the study shows the importance of considering the nutritional status in any child with a primary muscle disorder.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10332004      PMCID: PMC1717951          DOI: 10.1136/adc.80.6.542

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  28 in total

1.  Energy and nutrient intakes of children with spastic quadriplegia.

Authors:  M D Fried; P B Pencharz
Journal:  J Pediatr       Date:  1991-12       Impact factor: 4.406

2.  Characteristics and management of feeding problems of young children with cerebral palsy.

Authors:  S Reilly; D Skuse
Journal:  Dev Med Child Neurol       Date:  1992-05       Impact factor: 5.449

3.  Prevalence of feeding problems and oral motor dysfunction in children with cerebral palsy: a community survey.

Authors:  S Reilly; D Skuse; X Poblete
Journal:  J Pediatr       Date:  1996-12       Impact factor: 4.406

4.  Audit of outcome of long-term enteral nutrition by percutaneous endoscopic gastrostomy.

Authors:  M A Hull; J Rawlings; F E Murray; J Field; A S McIntyre; Y R Mahida; C J Hawkey; S P Allison
Journal:  Lancet       Date:  1993-04-03       Impact factor: 79.321

5.  The need for evaluation of gastroesophageal reflux in brain-damaged children referred for feeding gastrostomy.

Authors:  J R Wesley; A G Coran; T M Sarahan; M D Klein; S J White
Journal:  J Pediatr Surg       Date:  1981-12       Impact factor: 2.545

6.  Interview data on severe behavioural eating difficulties in young children.

Authors:  J E Douglas; M Bryon
Journal:  Arch Dis Child       Date:  1996-10       Impact factor: 3.791

7.  Symptomatic gastroesophageal reflux following gastrostomy in neurologically impaired patients.

Authors:  D L Mollitt; E S Golladay; J J Seibert
Journal:  Pediatrics       Date:  1985-06       Impact factor: 7.124

8.  Clinical phenotype in congenital muscular dystrophy: correlation with expression of merosin in skeletal muscle.

Authors:  J Philpot; C Sewry; J Pennock; V Dubowitz
Journal:  Neuromuscul Disord       Date:  1995-07       Impact factor: 4.296

9.  Determination of body composition from skinfold thickness: a validation study.

Authors:  J J Reilly; J Wilson; J V Durnin
Journal:  Arch Dis Child       Date:  1995-10       Impact factor: 3.791

10.  Congenital muscular dystrophy with merosin deficiency.

Authors:  F M Tomé; T Evangelista; A Leclerc; Y Sunada; E Manole; B Estournet; A Barois; K P Campbell; M Fardeau
Journal:  C R Acad Sci III       Date:  1994-04
View more
  17 in total

1.  Muscle-specific expression of insulin-like growth factor 1 improves outcome in Lama2Dy-w mice, a model for congenital muscular dystrophy type 1A.

Authors:  Ajay Kumar; Jenny Yamauchi; Tanya Girgenrath; Mahasweta Girgenrath
Journal:  Hum Mol Genet       Date:  2011-03-26       Impact factor: 6.150

2.  Transgenic overexpression of the α7 integrin reduces muscle pathology and improves viability in the dy(W) mouse model of merosin-deficient congenital muscular dystrophy type 1A.

Authors:  Jinger A Doe; Ryan D Wuebbles; Erika T Allred; Jachinta E Rooney; Margaret Elorza; Dean J Burkin
Journal:  J Cell Sci       Date:  2011-06-07       Impact factor: 5.285

3.  Laminin-111 improves muscle repair in a mouse model of merosin-deficient congenital muscular dystrophy.

Authors:  Pam M Van Ry; Priscilla Minogue; Bradley L Hodges; Dean J Burkin
Journal:  Hum Mol Genet       Date:  2013-09-05       Impact factor: 6.150

Review 4.  Diagnosis and management of cricopharyngeal achalasia and other upper esophageal sphincter opening disorders.

Authors:  I J Cook
Journal:  Curr Gastroenterol Rep       Date:  2000-06

5.  Laminin-111 protein therapy reduces muscle pathology and improves viability of a mouse model of merosin-deficient congenital muscular dystrophy.

Authors:  Jachinta E Rooney; Jolie R Knapp; Bradley L Hodges; Ryan D Wuebbles; Dean J Burkin
Journal:  Am J Pathol       Date:  2012-02-06       Impact factor: 4.307

Review 6.  Congenital or Early Developing Neuromuscular Diseases Affecting Feeding, Swallowing and Speech - A Review of the Literature from January 1998 to August 2021.

Authors:  Lotta Sjögreen; Lisa Bengtsson
Journal:  J Neuromuscul Dis       Date:  2022

Review 7.  Consensus statement on standard of care for congenital muscular dystrophies.

Authors:  Ching H Wang; Carsten G Bonnemann; Anne Rutkowski; Thomas Sejersen; Jonathan Bellini; Vanessa Battista; Julaine M Florence; Ulrike Schara; Pamela M Schuler; Karim Wahbi; Annie Aloysius; Robert O Bash; Christophe Béroud; Enrico Bertini; Kate Bushby; Ronald D Cohn; Anne M Connolly; Nicolas Deconinck; Isabelle Desguerre; Michelle Eagle; Brigitte Estournet-Mathiaud; Ana Ferreiro; Albert Fujak; Nathalie Goemans; Susan T Iannaccone; Patricia Jouinot; Marion Main; Paola Melacini; Wolfgang Mueller-Felber; Francesco Muntoni; Leslie L Nelson; Jes Rahbek; Susana Quijano-Roy; Caroline Sewry; Kari Storhaug; Anita Simonds; Brian Tseng; Jiri Vajsar; Andrea Vianello; Reinhard Zeller
Journal:  J Child Neurol       Date:  2010-11-15       Impact factor: 1.987

8.  173rd ENMC International Workshop: congenital muscular dystrophy outcome measures 5-7 March 2010, Naarden, The Netherlands.

Authors:  C G Bönnemann; A Rutkowski; E Mercuri; F Muntoni
Journal:  Neuromuscul Disord       Date:  2011-06-08       Impact factor: 4.296

Review 9.  Interventions for dysphagia in long-term, progressive muscle disease.

Authors:  Katherine Jones; Robert D S Pitceathly; Michael R Rose; Susan McGowan; Marguerite Hill; Umesh A Badrising; Tom Hughes
Journal:  Cochrane Database Syst Rev       Date:  2016-02-09

10.  A splice site mutation in laminin-α2 results in a severe muscular dystrophy and growth abnormalities in zebrafish.

Authors:  Vandana A Gupta; Genri Kawahara; Jennifer A Myers; Aye T Chen; Thomas E Hall; M Chiara Manzini; Peter D Currie; Yi Zhou; Leonard I Zon; Louis M Kunkel; Alan H Beggs
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.